Is axillary botulinum toxin efficient in controlling secondary Raynaud’s phenomenon? A case report
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Scleroderma and Related Disorders"
DOI: 10.1177/23971983211034077
Abstract: Raynaud’s phenomenon when secondary to underlying systemic disease such as systemic sclerosis occurs early in the disease course and progression can bring significant morbidity such as pain, digital ulceration, and necrosis. Standard medical therapies are… read more here.
Keywords: raynaud; axillary botulinum; raynaud phenomenon; case ... See more keywords